KDMP Financials 07/16/2014 12:51:38 Kedem Pharmac

KDMP Financials 07/16/2014 12:51:38
Kedem Pharmaceuticals, Inc.
Period Ending May 31, 2012 May 31, 2011 May 31, 2010
Total Revenue - - -
Cost of Revenue - - -
Gross Profit - - -
Operating Expenses
Research and Development 846 664 483
Sales, General and Admin. 1,395 1,328 1,308
Non-Recurring Items - 10 -
Other 109 35 20
Operating Income (2,351) (2,037) (1,811)
Income From Continuing Operations
Add'l Income/Expense Items (1,326) (192) -
Earnings Before Interest and Tax (3,677) (2,229) (1,811)
Interest Expense 2,229 1,943 168
Earnings Before Tax (5,906) (4,172) (1,979)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (6,876) (4,172) (1,979)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (5,906) (4,172) (1,979)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (5,906) (4,172) (1,979)